Literature DB >> 6693855

Biochemical characterization of a human parvovirus.

J P Clewley.   

Abstract

The buoyant density, nucleic acid, and proteins of the human serum parvovirus-like agent were investigated. Evidence is presented which suggests that the virus has genomic single-stranded DNA, and that complementary strands may be encapsidated in separate virions. Three proteins of 48 000, 68 000 and 80 000 mol. wt. were found to co-purify with viral antigen at a density of 1.43 g/ml on CsCl gradients. On the basis of these properties it is suggested that this virus is a parvovirus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693855     DOI: 10.1099/0022-1317-65-1-241

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Influence of extraction protocol on physical properties of parvovirus B19 DNA.

Authors:  Bertfried Matz; Bernd Kupfer; Thomas R Kreil; Anna Maria Eis-Hübinger
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

2.  Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

Authors:  H Sato; J Hirata; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.

Authors:  S F Cotmore; V C McKie; L J Anderson; C R Astell; P Tattersall
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus.

Authors:  G Gallinella; S Venturoli; G Gentilomi; M Musiani; M Zerbini
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  The human parvovirus. Brief review.

Authors:  M J Anderson; J R Pattison
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.

Authors:  H Sato; J Hirata; M Furukawa; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay.

Authors:  M Söderlund; K E Brown; O Meurman; K Hedman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro.

Authors:  N Young; M Harrison; J Moore; P Mortimer; R K Humphries
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

Authors:  Kanoktip Thammasri; Sanna Rauhamäki; Liping Wang; Artemis Filippou; Violetta Kivovich; Varpu Marjomäki; Stanley J Naides; Leona Gilbert
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.